GSK signed an exclusive licence deal with Hansoh Pharma in 2023, laying out up to $1.71bn in an upfront payment plus ...

Seeking thicker, stronger hair? Biotin gummies are popular, but store-bought versions often contain unwanted additives.

Myricx Bio, a cancer therapy spinout from Imperial’s Department of Chemistry, today announced it has reached agreement to be acquired by Novartis for up to $1.5 billion including $1.1 billion cash ...

GSK completes acquisition of Boston-based clinical-stage biopharma company, Nuvalent: London, UK Friday, July 17, 2026, 09:00 Hrs [IST] GSK plc announced completion of its acquisi ...

Sofinnova Partners, a leading European life sciences venture capital firm, today announced that its portfolio company Myricx Bio (“Myricx”) has reached agreement to be acquired by Novartis, for up to ...

After winning her first game, she said she was going for the tournament, but round two turned into a painful reminder of how ...

Let's take a look at some most searched hair growth ingredients with expert approval.

Swiss pharma heavyweight Novartis is cutting a very large check. The company has agreed to acquire London-headquartered ...

Biotin hair gummies can help make your hair stronger and improve its health. Learn about the ingredients, possible side effects, and hair care tips. | Health ...

Strengthens the Novartis oncology pipeline with two lead ADC assets and a broader payload platform with potential impact ...

Novartis will pay $1.1bn upfront and up to $400m in milestones for Myricx Bio, a UK firm developing a novel payload for antibody-drug conjugates.

GSK (GSK) announced on Friday a Phase 3 trial win in China for risvutatug rezetecan (Ris-Rez), an antibody-drug conjugate that the British drugmaker licensed from its Chinese partner Hansoh ...